Bombay HC tells Shreya Life to rename antibiotic drug
viaeconomictimes.indiatimes.com4d ago
The Bombay High Court has ordered the removal of Shreya Life Sciences’ antibiotic trademark Lefoxin Biox from the register, ruling that it was too similar to Glaxo Group’s long-established heart drug Lanoxin. The court gave Shreya until December 31 to rebrand and communicate the change, with the…
Khabar Adda curates headlines like this across Top Stories, Entertainment, Bollywood, Hollywood, Crime and Politics from public RSS feeds. This page links out to economictimes.indiatimes.com's own reporting rather than reproducing it — the excerpt above comes from economictimes.indiatimes.com's own feed.
Read the full story on economictimes.indiatimes.com ↗